论文信息 - Argx-110 Targeting CD70, in Combination with Azacitidine, Shows Favorable Safety Profile and Promising Anti-Leukemia Activity in Newly Diagnosed AML Patients in an Ongoing Phase 1/2 Clinical Trial - 字舞流文

Argx-110 Targeting CD70, in Combination with Azacitidine, Shows Favorable Safety Profile and Promising Anti-Leukemia Activity in Newly Diagnosed AML Patients in an Ongoing Phase 1/2 Clinical Trial

T. Pabst | M. Manz | Y. Banz | M. Bargetzi | M. Moshir | C. Riether | A. Ochsenbein | A. Hultberg | U. Bacher | S. Fung | N. Leupin | Tim Delahaye | D. Gandini | Rouven Müller | Magdalena Hinterbrandner | Ellen Erzeel | S. Höpner | Luc Van Rompaey | Hans de Haard